Serum lipoproteins and cancer

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 19, Issue 3, 2009, Pages 218-225

  Muntoni, S ^a,b   Atzori, L ^a   Mereu, R ^a   Satta, G ^a   Macis, M D ^a   Congia, M ^a   Tedde, A ^c   Desogus, A ^c  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b MEDICO Association   (Italy)

^c Ospedale Oncologico A Businco   (Italy)

Author keywords

Cancer; Hypertriglyceridaemia; Low HDL cholesterol; Tumoural progression marker

Indexed keywords

APOLIPOPROTEIN A1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; DISEASE COURSE; FEMALE; HUMAN; MALE; MIDDLE AGED; NEOPLASM; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN A-I; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; DISEASE PROGRESSION; FEMALE; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; NEOPLASMS; RETROSPECTIVE STUDIES; SEX FACTORS; TRIGLYCERIDES; YOUNG ADULT;

EID: 61649125626     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2008.06.002     Document Type: Article

References (34)

1. Rose G., Blackburn H., Keys A., Taylor H.L., Kannel W.B., Paul O., et al. Colon cancer and blood cholesterol. Lancet 1 (1974) 181-183
2. Peterson B., Trell E., and Sternby N.H. Low cholesterol level as risk factor for non coronary death in middle-aged men. JAMA 245 (1981) 2056-2057
3. Dessì S., Batetta B., Pulisci D., Accogli P., Pani P., and Broccia G. Total and HDL cholesterol in human hematologic neoplasms. Int J Hematol 54 (1991) 483-486
4. Spiegel R.J., Schaefer E.J., Magrath I.T., and Edwards B.K. Plasma lipid alterations in leukemia and lymphoma. Am J Med 72 (1982) 775-782
5. Vitols S., Björkholm M., Gahrton G., and Peterson C. Hypocholesterolaemia in malignancy due to elevated low-density-lipoprotein-receptor activity in tumour cells: evidence from studies in patients with leukemia. Lancet ii (1985) 1150-1154
6. Scribano D., Baroni S., Pagano L., Zuppi C., Leone G., and Giardina B. Return to normal values of lipid pattern after effective chemotherapy in acute lymphoblastic leukemia. Haematologica 81 (1996) 343-345
7. Kokoglu E., Karaarslan I., Karaarslan H.M., and Baloglu H. Alteration of serum lipids and lipoproteins in breast cancer. Cancer Lett 82 (1994) 175-178
8. Ray A., Jain D., Yadau R., Naik S.L., Sharma S., Bahadur A.K., et al. Effects of cancer treatment modalities on serum lipids and lipoproteins among women with carcinoma of the breast. Indian J Physiol Pharmacol 45 (2001) 337-344
9. Muntoni S., Stabilini L., Stabilini M., and Muntoni S. Results of a five-year community-based programme for cardiovascular disease prevention: The ATS-Sardegna Campaign. Eur J Epidemiol 15 (1999) 29-34
10. Allain C.C., Poon L.S., Chan C.S.G., Richmond W., and Fu P.C. Enzymatic determination of total cholesterol in serum. Clin Chem 20 (1974) 470-475
11. +2 precipitation procedure for quantitation of high-density lipoprotein cholesterol. Ann Ass Clin Chem 10 (1983) 91-99
12. Friedewald W.T., Levy J., and Fredrickson D.S. Estimation of the concentration of low-density-lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 18 (1972) 499-509
13. Spayd R., Bruschi B., Burdick B., Dappen G., Eikenberry J., and Esders T. Multilayer film elements for clinical analysis. Clin Chem 24 (1978) 1348-1350
14. Marcovina S.M., Albers J.J., Henderson L.O., and Hannon W.H. International Federation of Clinical Chemistry. Standardization Project for measurements of Apoliprotein A-1 and B. III. Comparability of Apolipoprotein A-1 values by use of international reference material. Clin Chem 39 (1993) 777-781
15. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative Oxygen receptor. Am Clin Biochem 6 (1969) 24-27
16. Bonora E., Targher G., Alberiche M., Bonadonna R.C., Saggiani F., Zenere M.B., et al. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23 (2000) 57-63
17. Hind C.R.H., and Pepys M.B. The role of serum C-reactive protein (CRP) measurement in clinical practice. Int Med 5 (1984) 112-151
18. Petrovas C., Daskas S.M., and Lianidou E.S. Determination of tumor necrosis factor-alpha (TNF-alpha) in serum by a highly sensitive enzyme amplified lanthanide luminescence immunoassay. Clin Biochem 32 (1999) 241-247
19. Therasse P., Arbuck S.G., Eisenhauer E.A., Wanders J., Kaplan R.S., Rubinstein L., et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92 3 (2000) 205-216
20. Brown C.D., Higgins M., Donato K.A., Rohde F.C., Garrison R., Obarzanek E., et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 8 (2000) 605-619
21. Garrison R.J., Kannel W.B., Feinleib M., Castelli W.P., McNamara P.M., and Padgett S.J. Cigarette smoking and HDL cholesterol: the Framingham offspring study. Atherosclerosis 30 (1978) 17-25
22. Glueck C.J., Hogg E., Allen C., and Gartside P.S. Effects of alcohol ingestion on lipids and lipoproteins in normal men: isocaloric metabolic studies. Am J Clin Nutr 33 (1980) 2287-2293
23. Reiser S., Hallfrisch J., Michaelis IV O.E., Lazar F.L., Martin R.E., and Prather E.S. Isocaloric exchange of dietary starch and sucrose in humans. I. Effects on levels of fasting blood lipids. Am J Clin Nutr 32 (1979) 1659-1669
24. Love R.R., Wiebe D.A., Feyzi J.M., Newcomb P.A., and Chappell R.J. Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment. J Natl Cancer Inst 86 (1994) 1534-1539
25. Barter P. Effects of inflammation on high density lipoproteins. Atheroscler Thromb Vasc Biol 22 (2002) 1062-1063
26. Barter P.J., Nichols S., Rye K.-A., Anantharamaiah G.M., Navab M., and Fogelman A.M. Antiinflammatory properties of HDL. Circ Res 95 (2004) 764-772
27. Assmann G., and Gotto Jr. A.M. HDL cholesterol and protective factors in atherosclerosis. Circulation 109 (2004) III8-III14
28. Ross R. Atherosclerosis. An inflammatory disease. N Engl J Med 340 (1999) 115-126
29. Marx J. Inflammation and cancer: the link grows stronger. Science 306 (2004) 966-968
30. Greten F.R., Eckmann L., Greten T.F., Park J.M., Egan L.J., Kagnoff M.F., et al. Ikkbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118 (2004) 285-296
31. Pikarsky E., Porat R.M., Stein I., Abramovitch R., Amits S., Kasem S., et al. NFKB functions as a tumour promoter in inflammation-associated cancer. Nature 431 (2004) 461-466
32. Koukourakis M.I., Pitiakoudis M., Giatromanolaki A., Tsarouha A., Polychronidis A., Sivridis E., et al. Oxigen and glucose consumption in gastrointestinal adenocarcinomas: correlation with markers of hypoxia, acidity and anaerobic glycolysis. Cancer Sci 97 (2006) 1056-1060
33. Nogouki Y., Yoshikawa T., Marat D., Doi C., Makino T., Fukuzawa K., et al. Insulin resistance in cancer patients is associated with enhanced tumor necrosis factor-alpha expression in skeletal muscle. Biochem Biophys Res Commun 253 (1998) 887-892
34. Yoshikawa T., Noguchi Y., Doi C., Makino T., and Nomura K. Insulin resistance in patients with cancer: Relationships with tumor site, tumor stage, body-weight loss, acute-phase response, and energy expenditure. Nutrition 17 (2001) 590-593